Nat Rev Drug Discov. 2009 Jan;8(1):23-33. Epub 2008 Dec 12.

Chemokine receptor antagonists: overcoming developmental hurdles.

Source

Richard Horuk is an adjunct professor at Touro University, 1310 Johnson Lane, Vallejo, California 94592, USA. Horuk@Pacbell.net

Abstract

Chemokine receptors have a key role in the pathogenesis of autoimmune diseases, inflammation and viral infection. However, with the exception of selective CCR5 antagonists for HIV, the promise of obtaining new therapeutics related to chemokine receptors has not yet been realized. This article highlights some of the recent failures in the clinical trials of chemokine receptor antagonists and explores possible reasons as to why this might have occurred. Such reasons include the lack of predictability of animal models and redundancy of the target. A potential solution could be to develop drugs that target more than one receptor--known as polypharmacology--which could be a novel way to generate effective therapeutics.

PMID:: 19079127; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review HIV chemokine receptor inhibitors as novel anti-HIV drugs. [Cytokine Growth Factor Rev. 2005]
Review HIV chemokine receptor inhibitors as novel anti-HIV drugs.
Princen K, Schols D. Cytokine Growth Factor Rev. 2005 Dec; 16(6):659-77. Epub 2005 Jul 6.
Overcoming hurdles in developing successful drugs targeting chemokine receptors. [Nat Rev Immunol. 2011]
Overcoming hurdles in developing successful drugs targeting chemokine receptors.
Schall TJ, Proudfoot AE. Nat Rev Immunol. 2011 May; 11(5):355-63. Epub 2011 Apr 15.
Review The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies. [J Clin Pharm Ther. 2009]
Review The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.
Dhami H, Fritz CE, Gankin B, Pak SH, Yi W, Seya MJ, Raffa RB, Nagar S. J Clin Pharm Ther. 2009 Apr; 34(2):147-60.
Review Anti-chemokine small molecule drugs: a promising future? [Expert Opin Investig Drugs. 2010]
Review Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE, Power CA, Schwarz MK. Expert Opin Investig Drugs. 2010 Mar; 19(3):345-55.
Review CCR1 antagonists for the treatment of autoimmune diseases. [Curr Opin Investig Drugs. 2004]
Review CCR1 antagonists for the treatment of autoimmune diseases.
Gladue RP, Zwillich SH, Clucas AT, Brown MF. Curr Opin Investig Drugs. 2004 May; 5(5):499-504.

See reviews... See all...

Cited by 11 PubMed Central articles

Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands. [Biochemistry. 2011]
Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands.
Knepp AM, Grunbeck A, Banerjee S, Sakmar TP, Huber T. Biochemistry. 2011 Feb 1; 50(4):502-11. Epub 2010 Dec 30.
Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. [Mol Pain. 2010]
Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain.
Serrano A, Paré M, McIntosh F, Elmes SJ, Martino G, Jomphe C, Lessard E, Lembo PM, Vaillancourt F, Perkins MN, et al. Mol Pain. 2010 Dec 10; 6:90. Epub 2010 Dec 10.
Emerging Concepts and Approaches for Chemokine-Receptor Drug Discovery. [Expert Opin Drug Discov. 2010]
Emerging Concepts and Approaches for Chemokine-Receptor Drug Discovery.
O'Hayre M, Salanga CL, Handel TM, Hamel DJ. Expert Opin Drug Discov. 2010 Nov; 5(11):1109-1122.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Chemokine receptor antagonists: overcoming developmental hurdles.
Chemokine receptor antagonists: overcoming developmental hurdles.
Nat Rev Drug Discov. 2009 Jan ;8(1):23-33. Epub 2008 Dec 12 .

PubMed
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a m...
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
Ann Pharmacother. 2005 Nov ;39(11):1798-807. Epub 2005 Sep 27 .

PubMed
D1 dopamine receptor dDA1 is required in the mushroom body neurons for aversive ...
D1 dopamine receptor dDA1 is required in the mushroom body neurons for aversive and appetitive learning in Drosophila.
J Neurosci. 2007 Jul 18 ;27(29):7640-7.

PubMed
Analysis of the role of autophagy in replication of herpes simplex virus in cell...
Analysis of the role of autophagy in replication of herpes simplex virus in cell culture.
J Virol. 2007 Nov ;81(22):12128-34. Epub 2007 Sep 12 .

PubMed
Mutations in PIP5K3 are associated with François-Neetens mouchetée fleck corneal...
Mutations in PIP5K3 are associated with François-Neetens mouchetée fleck corneal dystrophy.
Am J Hum Genet. 2005 Jul ;77(1):54-63. Epub 2005 May 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: